---
title: "VNDA: Fanapt® sales surged, BYSANTI™ gained FDA approval, and NEREUS™ launched in Q2 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295007537.md"
description: "Fanapt® drove strong prescription growth in Q2 2026, while total net product sales declined 4% year-over-year due to HETLIOZ® timing. BYSANTI™ received FDA approval, NEREUS™ launched, and multiple late-stage clinical milestones are expected by year-end.Original document: Vanda Pharmaceuticals Inc. [VNDA] SEC 8-K Current Report — Aug. 5 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-05T20:10:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295007537.md)
  - [en](https://longbridge.com/en/news/295007537.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295007537.md)
generator: "portal-rs"
---

# VNDA: Fanapt® sales surged, BYSANTI™ gained FDA approval, and NEREUS™ launched in Q2 2026

Fanapt® drove strong prescription growth in Q2 2026, while total net product sales declined 4% year-over-year due to HETLIOZ® timing. BYSANTI™ received FDA approval, NEREUS™ launched, and multiple late-stage clinical milestones are expected by year-end.

Original document: Vanda Pharmaceuticals Inc. \[VNDA\] SEC 8-K Current Report — Aug. 5 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [VNDA.US](https://longbridge.com/en/quote/VNDA.US.md)

## Related News & Research

- [Vanda says EU grants orphan drug status to imsidolimab for generalized pustular psoriasis](https://longbridge.com/en/news/296776870.md)
- [NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C. | VNDA Stock News](https://longbridge.com/en/news/296687031.md)
- [Bavarian Nordic Upgrades its Full-Year 2026 Financial Guidance](https://longbridge.com/en/news/296572606.md)
- [Public Storage announces R$ 0.41 per unit dividend for Q3 2026](https://longbridge.com/en/news/296635332.md)
- [Corning sets Q3 2026 dividend at R$ 0.25 per unit](https://longbridge.com/en/news/296635714.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**